Patent details
EP3999181 Title: POLYMORPHS OF (R)-N-(5-(5-ISOPROPYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-METHYL-2H-TETRAZOLE-5-CARBOXAMIDE
Basic Information
- Publication number:
- EP3999181
- PCT Application Number:
- US2020042390
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207535642
- PCT Publication Number:
- WO2021011809
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- POLYMORPHS OF (R)-N-(5-(5-ISOPROPYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-METHYL-2H-TETRAZOLE-5-CARBOXAMIDE
- French Title of Invention:
- POLYMORPHES DE (R)-N-(5-(5-ISOPROPYL -1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1 H-INDEN-1-YL)-2-MÉTHYL-2H-TÉTRAZOLE-5-CARBOXAMIDE
- German Title of Invention:
- POLYMORPHE DES (R)-N-(5-(5-ISOPROPYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-METHYL-2H-TETRAZOL-5-CARBOXAMIDS
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 28/06/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/09/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 29/05/2024
- Unitary Effect Registration Date:
- 02/09/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 16/07/2020
- Grant date:
- 29/05/2024
- EP Publication Date:
- 25/05/2022
- PCT Publication Date:
- 21/01/2021
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 29/05/2024
- EP B1 Publication Date:
- 29/05/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 16/07/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/05/2024
- Name:
- Cytokinetics, Inc.
- Address:
- 350 Oyster Point Blvd, South San Francisco CA 94080, United States (US)
Inventor
1
- Name:
- TOM, Norma
- Address:
- United States (US)
2
- Name:
- ANDERSEN, Denise
- Address:
- United States (US)
Priority
- Priority Number:
- 201962875355 P
- Priority Date:
- 17/07/2019
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 9/04; C07D 413/12; A61K 31/4196;
Publication
European Patent Bulletin
1
- Issue number:
- 202422
- Publication date:
- 29/05/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202432
- Publication date:
- 07/08/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202440
- Publication date:
- 02/10/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|